11/12
05:10 pm
aztr
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
Neutral
Report
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
11/12
05:05 pm
aztr
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates
Low
Report
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates
10/29
09:00 am
aztr
Azitra to Present at BIO-Europe 2024
Medium
Report
Azitra to Present at BIO-Europe 2024
10/11
09:00 am
aztr
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit
Low
Report
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit
9/24
08:00 am
aztr
Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress
Low
Report
Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress
9/18
09:00 am
aztr
Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors
High
Report
Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors
9/6
04:30 pm
aztr
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Medium
Report
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
8/29
07:24 am
aztr
Azitra doses first subject in Phase Ib Netherton syndrome treatment trial [Yahoo! Finance]
Medium
Report
Azitra doses first subject in Phase Ib Netherton syndrome treatment trial [Yahoo! Finance]
8/28
08:30 am
aztr
Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
Medium
Report
Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome
8/23
09:56 am
aztr
AZTR: First ATR-12 Patient Screened [Yahoo! Finance]
Low
Report
AZTR: First ATR-12 Patient Screened [Yahoo! Finance]
8/22
09:00 am
aztr
Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
Medium
Report
Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors
8/21
05:39 am
aztr
Azitra screens first subject in Phase Ib trial of ATR-12 for Netherton syndrome [Yahoo! Finance]
High
Report
Azitra screens first subject in Phase Ib trial of ATR-12 for Netherton syndrome [Yahoo! Finance]
8/20
04:29 pm
aztr
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome [Yahoo! Finance]
High
Report
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome [Yahoo! Finance]
8/20
04:15 pm
aztr
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome
Low
Report
Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome